1.
Revista Medica del Instituto Mexicano del Seguro Social
; 61(Suppl 1):33-36, 2022.
Article
in Spanish
| MEDLINE | ID: covidwho-2112072
ABSTRACT
Background: Since the beginning of the SARS-CoV-2 pandemic, identifying the COVID-19 pathophysiology not only has been addressed to applying diagnostic tests or preventing through vaccines, but also to the timely detection, especially of patients in risk groups such as those in transplants areas (renal, hematology, etcetera). In the case of these patients, using RT-PCR tests avoids putting them at risk by subjecting them to states of immunosuppression that could aggravate their situation if they were faced with an onset of a COVID-19 infection.